Correlation Between Cardio Diagnostics and Shuttle Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Cardio Diagnostics and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Shuttle Pharmaceuticals.
Diversification Opportunities for Cardio Diagnostics and Shuttle Pharmaceuticals
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cardio and Shuttle is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Shuttle Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Shuttle Pharmaceuticals
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 2.44 times more return on investment than Shuttle Pharmaceuticals. However, Cardio Diagnostics is 2.44 times more volatile than Shuttle Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Shuttle Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 130.00 in Cardio Diagnostics Holdings on September 5, 2024 and sell it today you would lose (100.00) from holding Cardio Diagnostics Holdings or give up 76.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. Shuttle Pharmaceuticals
Performance |
| Timeline |
| Cardio Diagnostics |
| Shuttle Pharmaceuticals |
Cardio Diagnostics and Shuttle Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and Shuttle Pharmaceuticals
The main advantage of trading using opposite Cardio Diagnostics and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
| Shuttle Pharmaceuticals vs. Lifecore Biomedical | Shuttle Pharmaceuticals vs. Catalent | Shuttle Pharmaceuticals vs. Tilray Inc | Shuttle Pharmaceuticals vs. Organogenesis Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |